From the Department of Neuroscience (A.W., A.A-B., Z.C., T.J.O., P.K., P.P.) and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Central Clinical School, Monash University; Department of Neurology (A.W., T.J.O., P.K., P.P.), Alfred Hospital; Departments of Neurology (A.W., T.J.O., P.K., P.P.) and Medicine (Z.C., T.J.O., P.K.), Royal Melbourne Hospital, and Department of Medicine (P.P.), Austin Health, University of Melbourne; and Comprehensive Epilepsy Program, Department of Neurology (P.P.), Austin Health, Melbourne, Victoria, Australia.
Neurology. 2022 Jan 18;98(3):e236-e248. doi: 10.1212/WNL.0000000000013066. Epub 2021 Dec 10.
Focal cortical dysplasia (FCD) has been associated with poorer postsurgical seizure outcomes compared to other pathologies. FCD surgical series have been assembled on the basis of a histologic diagnosis, including patients with abnormal and normal preoperative MRI. However, in clinical workflow, patient selection for surgery is based on preoperative findings, including MRI. We performed a systematic review and meta-analysis of the literature to determine the rate and predictors of favorable seizure outcome after surgery for MRI-detected FCD.
We devised our study protocol in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and registered the protocol with PROSPERO. We searched MEDLINE, EMBASE, and Web of Science for studies of patients followed up for ≥12 months after resective surgery for drug-resistant epilepsy with MRI-detected FCD. Random-effects meta-analysis was used to calculate the proportion of patients attaining a favorable outcome, defined as Engel class I, International League Against Epilepsy class 1 to 2, or seizure-free status. Meta-regression was performed to investigate sources of heterogeneity.
Our search identified 3,745 references. Of these, 35 studies (total of 1,353 patients) were included. Most studies (89%) followed up patients for ≥24 months after surgery. The overall postsurgical favorable outcome rate was 70% (95% confidence interval [CI] 64-75). There was high interstudy heterogeneity. Favorable outcome was associated with complete resection of the FCD lesion (risk ratio [RR] 2.42 [95% confidence interval (CI) 1.55-3.76], < 0.001) and location of the FCD lesion in the temporal lobe (RR 1.38 [95% CI 1.07-1.79], = 0.013) but not lesion extent, intracranial EEG use, or FCD histologic type. The number of FCD histologic types included in the same study accounted for 7.6% of the observed heterogeneity.
Seventy percent of patients with drug-resistant epilepsy and MRI features of FCD attain a favorable seizure outcome after resective surgery. Our findings can be incorporated into routine preoperative counseling and reinforce the importance of completely resecting the MRI-detected FCD when safe and feasible.
与其他病变相比,局灶性皮质发育不良(FCD)与术后癫痫发作结局较差相关。FCD 外科系列是基于组织学诊断而建立的,包括术前 MRI 异常和正常的患者。然而,在临床工作流程中,手术患者的选择是基于术前发现,包括 MRI。我们对文献进行了系统回顾和荟萃分析,以确定 MRI 检测到的 FCD 手术后手术治疗的良好癫痫发作结局的发生率和预测因素。
我们根据系统评价和荟萃分析的首选报告项目制定了我们的研究方案,并在 PROSPERO 上注册了该方案。我们检索了 MEDLINE、EMBASE 和 Web of Science,以获取接受药物难治性癫痫切除性手术治疗且 MRI 检测到 FCD 的患者随访时间≥12 个月的研究。使用随机效应荟萃分析计算达到良好结局的患者比例,定义为 Engel 分级 I、国际抗癫痫联盟分级 1-2 或无癫痫发作状态。进行荟萃回归分析以调查异质性的来源。
我们的搜索共确定了 3745 条参考文献。其中,有 35 项研究(共 1353 名患者)被纳入。大多数研究(89%)在手术后随访患者≥24 个月。术后总体良好结局率为 70%(95%置信区间 [CI] 64-75)。研究间存在高度异质性。良好结局与 FCD 病变的完全切除(风险比 [RR] 2.42 [95% CI 1.55-3.76], < 0.001)和 FCD 病变位于颞叶(RR 1.38 [95% CI 1.07-1.79], = 0.013)有关,但与病变范围、颅内脑电图的使用或 FCD 的组织学类型无关。同一研究中包含的 FCD 组织学类型数量占观察到的异质性的 7.6%。
70%的药物难治性癫痫且 MRI 特征符合 FCD 的患者在接受切除性手术后获得了良好的癫痫发作结局。我们的发现可以纳入常规术前咨询,并强调在安全可行的情况下完全切除 MRI 检测到的 FCD 的重要性。